To outcompete China, unhandcuff America’s biotech innovators

From The Hill

Former official David Mansdoerfer argues that bureaucratic delays at the FDA threaten American leadership in the growing regenerative medicine sector and give international competitors like China a strategic advantage.

Source Author
Author: Source Author

Written by

David Mansdoerfer, opinion contributor

in

More posts